Kevin Martínez Pérez

Dr. Kevin Martínez Pérez

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
KPKevin Martínez Pérez
Kevin Martínez Pérez
DTDANIELA TORRES
DANIELA TORRES
NSNathalia Sanclemente
Nathalia Sanclemente
OROscar Ramirez
Oscar Ramirez
APAndrés Portilla
Andrés Portilla
ELEduardo López-Medina
Eduardo López-Medina
A history of invasive mold disease (IMD) often delays or contraindicates allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. Given the limited data on pediatric patients with pre-allo-HSCT IMD, we aimed to describe the management and clinical outcomes of a cohort of children with IMD prior to allo-HSCT through day +100 post-transplantation. Between 2021 and 2024, ten pediatric patients were identified with proven or probable IMD. Their median age was 8.5 years. The most common pathogens were Aspergillus (n = 5) and Fusarium (n = 4). Infections most frequently involved the lungs followed by paranasal sinuses, bloodstream, liver, and skin. All patients demonstrated clinical improvement before transplantation, and by day +100 post-HSCT, no IMD relapses or infection-related mortality were observed. These findings suggest that complete radiologic or clinical resolution is not a prerequisite for proceeding with transplantation. Recent IMD should not be considered an absolute contraindication to urgent allo-HSCT when clinical improvement is evident, as transplantation facilitates immune reconstitution necessary for definitive infection control.

3 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DTDANIELA TORRES
DANIELA TORRES
KPKevin Martínez Pérez
Kevin Martínez Pérez
CMCindy Daiana Marmolejo
Cindy Daiana Marmolejo
Jenny Patricia Muñoz-LomboJenny Patricia Muñoz-Lombo
Jenny Patricia Muñoz-Lombo
HGHerney Andres García-Perdomo
Herney Andres García-Perdomo
JRJuan Pablo Rojas-Hernández
Juan Pablo Rojas-Hernández
Human T-cell lymphotropic virus type 1 (HTLV-1) affects between 10 and 20 million people worldwide and remains a neglected infection in endemic areas such as southwestern Colombia. This study aimed to describe the clinical and demographic characteristics of forty-four patients with confirmed HTLV-1 infection treated at a referral center between January 2021 and December 2023. A retrospective case series analysis was conducted, including twenty-three pediatric patients, sixteen adults, and five pregnant women, with confirmation by Western Blot. Among the pediatric population, 52.2% presented with anemia, leukocytosis, and pulmonary coinfections, mainly due to Aspergillus spp. and Mycobacterium tuberculosis; 47.8% had infective dermatitis, and 45.5% had malnutrition. In adults, adult T-cell leukemia/lymphoma (ATLL) was the main manifestation (56.3%), followed by neurological involvement (43.7%). The mortality rate among adults was 68.7%, and one death was recorded in the pediatric group. The pregnant women had a mean age of 33 years and an average gestational age of 31.6 weeks at diagnosis; all were asymptomatic carriers. These findings highlight the clinical burden of HTLV-1 across different age groups and reinforce the need to implement public health strategies, including prenatal screening and comprehensive clinical follow-up in endemic areas.